Skip to content
Back to Insights
Spatial Biology

Weekly data spotlight — cost-effective single-cell analysis through spatial transcriptomics

STAMP profiles individual cells via image-based spatial transcriptomics — ~50× cheaper per cell than scRNA-seq, with rare-cell detection at 1:100,000 dilutions and direct visual validation.

DL
Daeseung Lee October 19, 2024 - 5 min read
Share
STAMP — image-based spatial transcriptomics at single-cell scale
STAMP — image-based spatial transcriptomics at single-cell scale

Cost-effective and scalable single-cell analysis through spatial transcriptomics

Recently, a method called Single-cell Transcriptomics Analysis and Multimodal Profiling (STAMP) has been introduced that allows for large-scale profiling of individual cells. Instead of scRNA-seq, this technique involves spraying cells in suspension and reading them through image-based spatial transcriptomics (ST) and proteomics. Compared to conventional scRNA-seq, this method has the following advantages:

  1. it is more cost-effective,
  2. it can identify scarce cell populations, such as circulating tumor cells (CTCs), and
  3. it can now leverage data like tissue-specific environments and the subcellular localization of RNA within a spatial biology framework.

Per-cell cost — ST is ~50× cheaper

According to a reference from Genomics Colab at UCSF, the per-cell cost of scRNA-seq is significantly higher than Xenium. While one scRNA-seq sample typically covers around 10,000 cells, Xenium can analyze approximately 500,000 to 1,000,000 cells per sample. When comparing per-cell costs, image-based ST using Xenium is about 50 times cheaper than scRNA-seq. Image-based ST therefore offers a much more cost-effective approach on a per-cell basis.

Detecting rare cells — CTCs at 1:100,000

STAMP detected rare cell types such as circulating tumor cells (CTCs) by spiking MCF-7 cancer cells at dilutions of 1:100,000 and 1:50,000 into peripheral blood mononuclear cells (PBMCs), successfully identifying these rare populations with high sensitivity. Image-based ST in STAMP allows direct visual validation of rare cells through imaging in addition to molecular profiling. This non-destructive approach enables identification of rare cell types like CTCs by capturing spatial and morphological data — something difficult to achieve with sequencing alone. Consistent with this, a recent paper in Cancer Cell reported that a combined analysis of transcriptome and cell morphology can enable novel state and cell-type discovery and clinical prognosis.

Spatial context beyond cost

Although STAMP doesn’t explicitly address it, the advantages of spatial biology extend beyond cost. Spatially close cell-cell interaction and cell-type composition add information in the spatial context, as with Nicheformer. Subcellular RNA locations have been used in numerous cases.

Image-based ST has traditionally been known for its limited gene coverage, but significant improvements are being made — Xenium 5k and MERSCOPE 1k gene panels. Image-based ST now allows simultaneous protein profiling alongside transcriptome analysis, expanding its capabilities, as seen in STAMP. As a result, the decision to opt for ST over scRNA-seq is becoming increasingly popular, thanks to these advancements and the growing versatility of image-based approaches.

Recommended reads